- Cell Culture Technology,
- High Throughput Technology,
- Molecular Imaging,
- OMICS Technology
In vitro Toxicology Market size was valued at USD 10.2 billion in 2022 and is expected to grow USD 21.2 billion by 2029 at a CAGR of 11.1% from 2023 to 2029. The global market report provides a detailed overview of the In vitro Toxicology Market, which has been segmented by technology, method, application, and end-user. The In vitro Toxicology Market has been segmented by technology into Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology. The Cell Culture Technology segment is likely the largest and fastest growing in terms of technology. This method has segmented the In vitro Toxicology Market into Cellular Assay, Biochemical Assay, In Silico, and Ex-vivo. The Cellular Assay segment will gain the maximum revenue share over the forecast period. The In vitro Toxicology Market has been segmented into Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, and Others. The Dermal Toxicity segment is expected to account for the high revenue share in 2022-2028. Based on end-user, the in-vitro toxicology is segmented into the Pharmaceutical Industry, Cosmetics and household Products, Diagnostics, Chemicals Industry, and Food Industry. According to Precision Business Insights, the Chemicals Industry segment is predicted to register the fastest growth rate during the forecast period.
In vitro Toxicology Market Key Development:
- In March 2022, Laboratory Corporation of America Holdings acquired AtlantiCare Diagnostics clinical laboratory services.
Global In Vitro Toxicology Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.1%
Largest Market
North America
Fastest Growing Market
Asia Pacific
In vitro Toxicology Market Dynamics
An increase in the number of R&D activities that require in vitro testing, a restriction on animal testing, and increased awareness about environmental concerns are the factors driving the global in vitro toxicology testing market, which is likely to develop significantly throughout the forecast period.
North-America Got Significant Share
In vitro Toxicology Market Regional Analysis
The North American market is expected to witness the highest market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The in vitro toxicology market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The in vitro toxicology market report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The in vitro toxicology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The in vitro toxicology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The in vitro toxicology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global In Vitro Toxicology Market Segmentation
By Technology
By Application
- Systemic Toxicology,
- Dermal Toxicity,
- Endocrine Disruption,
- Ocular Toxicity,
- Others
By End User
- Pharmaceutical Industry,
- Cosmetics & Household Products,
- Diagnostics,
- Chemicals Industry,
- Food Industry
By Geography
- Latin America
- Europe
- Asia Pacific
- Middle East
- North America
Frequently Asked Questions
The in vitro toxicology market is projected to expand at a CAGR of 11.1% during the forecast period.
The major players in the global In-vitro Toxicology market are ??? Agilent Technologies, Inc., Abbott, Beckman Coulter, Inc., Merck KGaA, Dassault Systèmes, GENERAL ELECTRIC COMPANY, Quest Diagnostics Incorporated, Labcorp Drug Development, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories International, Inc.
North America is the fastest-growing region for in-vitro toxicology market
| 1. Executive Summary |
| 2. Global In vitro Toxicology Market Introduction |
| 2.1. Global In vitro Toxicology Market - Taxonomy |
| 2.2. Global In vitro Toxicology Market -Definitions |
| 2.2.1. By Technology |
| 2.2.2. By Method |
| 2.2.3. By Application |
| 3. Global In vitro Toxicology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global In vitro Toxicology Market Dynamic Factors - Impact Analysis |
| 4. Global In vitro Toxicology Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global In vitro Toxicology Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Cell Culture Technology |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. High Throughput Technology |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Molecular Imaging |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. OMICS Technology |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global In vitro Toxicology Market Forecast, By Method, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. Cellular Assay |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Biochemical Assay |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. In Silico |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Ex-vivo |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global In vitro Toxicology Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Systemic Toxicology |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Dermal Toxicity |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Endocrine Disruption |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Ocular Toxicity |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global In vitro Toxicology Market Forecast, By End-user, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. Pharmaceutical Industry |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Cosmetics & Household Products |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostics |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Chemicals Industry |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Food Industry |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global In vitro Toxicology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application, End-user and Region, 2023 - 2029 |
| 10. North America In-vitro ToxicologyMarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Cell Culture Technology |
| 10.1.2. High Throughput Technology |
| 10.1.3. Molecular Imaging |
| 10.1.4. OMICS Technology |
| 10.2. Method Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Cellular Assay |
| 10.2.2. Biochemical Assay |
| 10.2.3. In Silico |
| 10.2.4. Ex-vivo |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Systemic Toxicology |
| 10.3.2. Dermal Toxicity |
| 10.3.3. Endocrine Disruption |
| 10.3.4. Ocular Toxicity |
| 10.3.5. Others |
| 10.4. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Pharmaceutical Industry |
| 10.4.2. Cosmetics & Household Products |
| 10.4.3. Diagnostics |
| 10.4.4. Chemicals Industry |
| 10.4.5. Food Industry |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2023 - 2029 |
| 10.7. North America In vitro Toxicology Market Dynamics - Trends |
| 11. Europe In vitro Toxicology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Cell Culture Technology |
| 11.1.2. High Throughput Technology |
| 11.1.3. Molecular Imaging |
| 11.1.4. OMICS Technology |
| 11.2. Method Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Cellular Assay |
| 11.2.2. Biochemical Assay |
| 11.2.3. In Silico |
| 11.2.4. Ex-vivo |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Systemic Toxicology |
| 11.3.2. Dermal Toxicity |
| 11.3.3. Endocrine Disruption |
| 11.3.4. Ocular Toxicity |
| 11.3.5. Others |
| 11.4. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Pharmaceutical Industry |
| 11.4.2. Cosmetics & Household Products |
| 11.4.3. Diagnostics |
| 11.4.4. Chemicals Industry |
| 11.4.5. Food Industry |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Poland |
| 11.5.8. Rest of Europe |
| 11.6. Europe In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2023 - 2029 |
| 11.7. Europe In vitro Toxicology Market Dynamics - Trends |
| 12. Asia-Pacific In vitro Toxicology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Cell Culture Technology |
| 12.1.2. High Throughput Technology |
| 12.1.3. Molecular Imaging |
| 12.1.4. OMICS Technology |
| 12.2. Method Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Cellular Assay |
| 12.2.2. Biochemical Assay |
| 12.2.3. In Silico |
| 12.2.4. Ex-vivo |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Systemic Toxicology |
| 12.3.2. Dermal Toxicity |
| 12.3.3. Endocrine Disruption |
| 12.3.4. Ocular Toxicity |
| 12.3.5. Others |
| 12.4. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Pharmaceutical Industry |
| 12.4.2. Cosmetics & Household Products |
| 12.4.3. Diagnostics |
| 12.4.4. Chemicals Industry |
| 12.4.5. Food Industry |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2023 - 2029 |
| 12.7. Asia-Pacific In vitro Toxicology Market Dynamics - Trends |
| 13. Latin America In vitro Toxicology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Cell Culture Technology |
| 13.1.2. High Throughput Technology |
| 13.1.3. Molecular Imaging |
| 13.1.4. OMICS Technology |
| 13.2. Method Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Cellular Assay |
| 13.2.2. Biochemical Assay |
| 13.2.3. In Silico |
| 13.2.4. Ex-vivo |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Systemic Toxicology |
| 13.3.2. Dermal Toxicity |
| 13.3.3. Endocrine Disruption |
| 13.3.4. Ocular Toxicity |
| 13.3.5. Others |
| 13.4. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Pharmaceutical Industry |
| 13.4.2. Cosmetics & Household Products |
| 13.4.3. Diagnostics |
| 13.4.4. Chemicals Industry |
| 13.4.5. Food Industry |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Argentina |
| 13.5.4. Rest of Latin America |
| 13.6. Latin America In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2023 - 2029 |
| 13.7. Latin America In vitro Toxicology Market Dynamics - Trends |
| 14. Middle East and Africa In vitro Toxicology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 14.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Cell Culture Technology |
| 14.1.2. High Throughput Technology |
| 14.1.3. Molecular Imaging |
| 14.1.4. OMICS Technology |
| 14.2. Method Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Cellular Assay |
| 14.2.2. Biochemical Assay |
| 14.2.3. In Silico |
| 14.2.4. Ex-vivo |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Systemic Toxicology |
| 14.3.2. Dermal Toxicity |
| 14.3.3. Endocrine Disruption |
| 14.3.4. Ocular Toxicity |
| 14.3.5. Others |
| 14.4. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Pharmaceutical Industry |
| 14.4.2. Cosmetics & Household Products |
| 14.4.3. Diagnostics |
| 14.4.4. Chemicals Industry |
| 14.4.5. Food Industry |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. Israel |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2023 - 2029 |
| 14.7. MEA In vitro Toxicology Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Method& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Charles River |
| 15.2.2. Catalent, Inc. |
| 15.2.3. Eurofins Scientific |
| 15.2.4. Quest Diagnostics Incorporated |
| 15.2.5. Laboratory Corporation of America Holdings |
| 15.2.6. Evotec |
| 15.2.7. Creative Bioarray |
| 15.2.8. Gentronix |
| 15.2.9. HD Biosciences Co., Ltd. |
| 15.2.10. MB Research Laboratories |
| 15.2.11. BioIVT |
| 15.2.12. SGS SA |
| 15.2.13. GVK Biosciences Private Limited |
| 15.2.14. InSphero |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Charles River
- Catalent, Inc.
- Eurofins Scientific
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Evotec
- Creative Bioarray
- Gentronix
- HD Biosciences Co., Ltd.
- MB Research Laboratories
- BioIVT
- SGS SA
- GVK Biosciences Private Limited
- InSphero